ADMA BIOLOGICS INC - COMMON STOCK

16.69

07-February-25 09:33:49

15 minutes delayed

Stocks

-0.23

-1.36%

Today's range

16.68 - 17.06

ISIN

N/A

Source

NASDAQ

ADMA Biologics Reports Fourth Quarter and Full Year 2020 Financial Results

25 Mar 2021 15:05:01 By Nasdaq GlobeNewswire
ADMA Biologics to Report Fourth Quarter and Full Year 2020 Financial Results on March 25, 2021

18 Mar 2021 07:00:00 By Nasdaq GlobeNewswire
ADMA Biologics to Participate in the Jefferies Virtual Plasma Summit

04 Mar 2021 07:00:02 By Nasdaq GlobeNewswire
ADMA Biologics Expands Global Regulatory Approval Presence and Announces FDA Approval to Commence Hepatitis B Plasma Collections

03 Mar 2021 07:00:01 By Nasdaq GlobeNewswire
ADMA Biologics Presents Late-Breaking Poster Presentation Highlighting Clinical Utility of S. Pneumoniae Hyperimmune Globulin at the 2021 American Academy of Allergy, Asthma & Immunology Virtual Annual Meeting

26 Feb 2021 07:00:00 By Nasdaq GlobeNewswire
ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Knoxville, TN

01 Feb 2021 07:00:01 By Nasdaq GlobeNewswire
ADMA Biologics Receives Unique Permanent J-Code for ASCENIV™

26 Jan 2021 07:00:02 By Nasdaq GlobeNewswire
ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2020 Revenues and Provides 2021 Strategic Outlook

19 Jan 2021 07:00:01 By Nasdaq GlobeNewswire
ADMA Biologics Receives Unique Temporary C-Code and Pass-Through Payment Status for ASCENIV™

04 Jan 2021 07:00:01 By Nasdaq GlobeNewswire

<<
<
4
5
6
7
8
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.